Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,266
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,852
Class I recallsReasonable probability of serious health consequences
24,397
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,085 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2

Showing 101–120 of 21,230 recalls

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bars Strawberry, Pineapple, Grape, Tangerine.…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bars Black Cherry, 6 Bars, 2.5 ounce, with UP…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bars Tangerine, 6-Count 2.5 ounce, with UPC 0…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bars Grape, 6-Count 2.5 ounce, with UPC 04154…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bar Watermelon, 6-Count 2.5 ounce with UPC 04…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall United States Ongoing2026 recordClass II

Dreyer's Grand Ice Cream Inc.

Product
Outshine Fruit Bars Strawberry, 6-Count 2.5 ounce, with UPC…
Reason
Foreign object: products may contain glass pieces
Published
September 2, 2026
Distribution
The adulterated product was distributed…

View recall →

FDA Recall Ongoing2026 recordClass II

niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose vials (NDC 0517-9305-01) and b) 5x1mL Single Dose vials (NDC 0517-9305-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in a) 1 mL Single-Dose Vial (NDC 0517-9302-01), and b) 25x1 mL Single-Dose Vials (NDC 0517-9302-25) Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose Vial (NDC 0517-6502-10), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7604-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7504-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only, American Regent, Inc., Shirley, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Cyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Only, packaged in a) 10 mL Multi-Dose Vial (NDC 0517-0032-01) and b) 25x10 mL Multi-Dose Vials (NDC 0517-0032-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDC 0517-0031-01), and b) 25x1 mL Multi-Dose Vials (NDC 0517-0031-25) Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials (NDC 0517-4810-01), b) 25x10mL vials (NDC 0517-4810-25) RX only, AMERICAN REGENT, INC., Shirley, NY 11967.

by American Regent, Inc.

Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11

by Fresenius Kabi USA, LLC

Reason
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Published
August 26, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.

by MYLAN PHARMACEUTICALS INC

Reason
Failed Dissolution Specifications
Published
August 26, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.